Aminocaproic Acid Oral Suspension (Anhydrous)

How to Give Anhydrous Oral Suspension

Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:

1. Shake well each time to mix the medication (5-10 seconds).
2. Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
3. Hold your pet steady: a towel or helper can assist with squirmy pets.
4. Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
5. Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
6. Praise your pet and offer a treat or water (unless advised against feeding right after).
7. Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
8. Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.

The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.

Veterinarians most commonly consider aminocaproic acid when there is a clinical need to stabilize a blood clot and may help reduce its premature dissolution. In dogs, it is a point of discussion for the management of postoperative bleeding, especially in Greyhound breeds where a unique physiological tendency toward hyperfibrinolysis has been observed. In equine medicine, veterinarians may evaluate its use in the context of exercise-induced pulmonary hemorrhage or other situations where maintaining hemostasis is a primary objective.

At a pharmacological level, aminocaproic acid acts as a competitive inhibitor of plasminogen activation. By binding to the lysine-binding sites of plasminogen, it is understood to inhibit the conversion of plasminogen to plasmin, the enzyme responsible for the degradation of fibrin clots. This mechanism does not promote the formation of new clots but rather supports the longevity of those already formed by the body's natural processes. A veterinarian will determine if this medication is appropriate based on your pet’s species, the specific clinical context and the results of diagnostic blood work.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.

Commonly observed effects of aminocaproic acid are relatively infrequent but may include gastrointestinal upset, such as vomiting or diarrhea. In some patients, restlessness or mild behavioral changes have been noted following administration. Because the medication influences the body's ability to break down clots, your veterinarian will monitor for any signs of unintended thrombus formation. If you observe persistent lethargy, significant changes in appetite or localized swelling, contact your veterinarian promptly.

This medication is typically used with extra caution or avoided in patients with a known history of active intravascular clotting or certain renal conditions, as the medication is primarily excreted through the kidneys. It is also important to inform your veterinarian if your pet is currently receiving other medications that affect hemostasis or blood pressure, as these can interact with aminocaproic acid. Your veterinarian is the best resource for designing a management plan that incorporates this medication safely into your pet’s care protocol.